Medical News

RSS

Stem cell research updates

Two studies have been published this Wednesday in the journal Nature that show that work remains before so-called induced pluripotent stem (iPS) cells are ready for use in laboratory studies or clinical therapies. These iPS cells are body cells that are programmed to unwind back into an embryonic state. Like embryonic stem cells, they have potential to develop into any other type of cell in the body. However researchers are showing that these cells do not reprogram perfectly.

3 Mar 2011

Scientist receives $4 million Australia fellowship to continue cancer origin research

Walter and Eliza Hall Institute cancer researcher Professor Jane Visvader has received a $4 million fellowship from the Australian Government to continue her work into the origin of breast, ovarian and lung cancers.

3 Mar 2011

CAS is an economically attractive alternative to endarterectomy for stroke patients

Researchers determined that carotid artery stenting with embolic protection is an economically attractive alternative to endarterectomy for patients at increased surgical risk.

3 Mar 2011

Mater improves communication with external healthcare providers

A pilot of new web-based software designed to improve communication between Mater Health Services and external providers is being rolled out across Brisbane.

3 Mar 2011

Baby frozen to correct brain damage at birth makes full recovery

Baby Ella was born starved of oxygen but doctors cooled her body for three days to reduce brain damage. She made a complete recovery. After birth Ella was wrapped in a special blanket filled with fluid which cooled her whole body down from the normal 37°c to 33.5°c by doctors at Addenbrooke’s Hospital in Cambridge.

3 Mar 2011

BIOTRONIK launches new Renamic implantable cardiac device in Europe

BIOTRONIK SE & Co. KG announced today the European market launch of their new Renamic implantable cardiac device programmer. Renamic is the latest addition to BIOTRONIK's new portfolio of external devices launched within only a few months.

3 Mar 2011

Marijuana and psychosis linked in a study

...

3 Mar 2011

Community gym surfaces do not appear to be reservoirs for MRSA transmission

Community gym surfaces do not appear to be reservoirs for MRSA transmission, according to a study published in the March issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

3 Mar 2011

Honey for wound healing: Study

Researchers from the University of Queensland (UQ) and the Queensland Government have found honey from an Australian native myrtle to be effective as an anti-bacterial agent that can be used to treat wounds and viruses.

3 Mar 2011

DNA methylation patterns can accurately detect early bowel cancer

Cancer Research UK scientists have discovered for the first time that DNA methylation patterns - a key process in cell development - could accurately detect early bowel cancer, according to research published in Gut, today.

3 Mar 2011

VICC introduces nation's first personalized cancer decision support tool

Vanderbilt-Ingram Cancer Center has launched the nation's first personalized cancer decision support tool, "My Cancer Genome," to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients.

3 Mar 2011

BMC partners with YMCA of Greater Boston to form END Diabetes Program

In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.

3 Mar 2011

New study provides fascinating insight into genetic basis of bipolar disorder

A new study provides fascinating insight into the genetic basis of bipolar disorder, a highly heritable mood disorder characterized by recurrent episodes of mania and depression.

3 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.

3 Mar 2011

Scientists uncover genetic pathway that affects breast cancer development

Using recent advances in genomics, researchers have uncovered a genetic pathway that affects the development of breast cancer, work that could help predict which patients are at risk of relapse for the disease.

3 Mar 2011

Racial and ethnic groups less likely to receive kidney transplants than others

Not all racial and ethnic groups have equal access to kidney transplantation, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results indicate that the reasons for these disparities are varied and that more focused efforts are needed to address them.

3 Mar 2011

FDA approves Amneal's Indomethacin ER capsules

Amneal Pharmaceuticals, LLC is pleased to announce that it received U.S. FDA approval for Indomethacin Extended Release capsules, USP in the 75 mg strength effective December 1, 2010.

3 Mar 2011

dicomPACS®DX-R 2.0 sets new standards in image processing

OR Technology will present a new version of its X-ray acquisition software at this year’s ECR (European Congress of Radiology) in Vienna. dicomPACS®DX-R version 2.0 provides extended image processing – Cognition Optimised Processing. New adjustment options such as automatic pixel correction reduce image interference and improve the overall impression of the image. Optimal contrast regulation covering the entire image ensures improved recognition of details in soft tissue and bones.

3 Mar 2011

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Future Medicine Ltd has today announced the launch of Neurodegenerative Disease Management – a new bimonthly title addressing all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world.

3 Mar 2011